Literature DB >> 6795267

Mouse myeloma proteins with lambda 2 and lambda 3 light chains.

T Cotner, K Blaser, J Kriedberg, M Potter, H N Eisen.   

Abstract

Serum and ascites fluid from mice bearing 260 different myeloma tumors were screened serologically for myeloma proteins having light chains like that of L315, the lambda 2 chain produced by myeloma MOPC-315. Four proteins, made by myelomas TEPC-952, CBPC-49, ABPC-72, and SAPC-15, were identified. Their light chains were essentially indistinguishable serologically from L315, and each of them also yielded the characteristic C-terminal amino acid (leucine) and C-terminal tryptic peptide of L315. However, amino acid sequences and other findings reported elsewhere have revealed that although the light chain of TEPC-952 is indeed a lambda 2 chain, the light chains of the others (CBPC-49, ABPC-72, and SAPC-15) represent another, slightly different type of light chain, which has been designated lambda 3.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795267

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Activation of idiotype-specific CD4+ T-cell line: cellular processing of exogenous self-immunoglobulin.

Authors:  N Sakato; P Rugdech; T Yoda; A Ota; Y Zhao; M Semma; Y Suzuki; H Fujio
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.

Authors:  N Sakato; M Semma; H N Eisen; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Diversity at the variable-joining region boundary of lambda light chains has a pronounced effect on immunoglobulin ligand-binding activity.

Authors:  T Azuma; V Igras; E B Reilly; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

4.  Fine specificity analysis of idiotype-specific suppressor factors that block a delayed-type hypersensitivity response to M315: evidence supporting a role for somatic mutations in the variable region of the lambda 2 chain of M315.

Authors:  N Sakato; T Azuma; H Fujio
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.